Opening: Check-up report scenario (Random mechanism #3)
A check-up report showing AMH 0.8 ng/mL and FSH 12.5 IU/L lies on the consultation desk. The patient is 35 years old, has been trying to conceive for two years without success, and a hysterosalpingography from another hospital indicates bilateral tubal patency but with poor function. This is a common scenario at the Xiangya Hospital Reproductive Medicine Center outpatient clinic—diminished ovarian reserve combined with tubal factor. In the consultation room, the most frequent question patients ask is: "Doctor, what is the actual success rate here?"
Behind this question lies a great deal of anxiety and expectation. To answer it, one cannot simply give a single number. Instead, it is necessary to deconstruct the true meaning of "success rate" in the context of assisted reproduction and identify the factors that genuinely influence it.
1. Direct Answer: Success Rate is a Range, Not a Fixed Number
As an institution approved by the National Health Commission to carry out assisted reproductive technology, the clinical pregnancy rate of Xiangya Hospital Reproductive Medicine Center is within the same range as other large-scale reproductive centers of similar level in China. However, it must be clarified: The success rate is never a fixed number but a range that dynamically changes based on variables such as patient age, ovarian reserve, etiology, and embryo quality.
Based on routine data from large domestic reproductive centers (not exclusive to Xiangya Hospital):
| Age Group | Clinical Pregnancy Rate Reference Range (per transfer cycle) | Cumulative Live Birth Rate Reference Range |
|---|---|---|
| <35 years | Approximately 50% – 65% | Approximately 60% – 75% |
| 35 – 37 years | Approximately 40% – 52% | Approximately 50% – 62% |
| 38 – 40 years | Approximately 28% – 40% | Approximately 35% – 48% |
| 41 – 42 years | Approximately 18% – 28% | Approximately 22% – 34% |
| ≥43 years | Approximately 8% – 18% | Approximately 10% – 20% |
2. Why There is Such a Large Individual Difference in Success Rate
The core source of success rate variation is biological variables, not the technology itself. Within the same reproductive center, using the same culture system and procedures, outcomes for different patients can be completely different.
- Age and Ovarian Reserve: Oocyte quality declines with age, which is the most direct factor affecting success rate. After age 35, the rate of chromosomal aneuploidy increases significantly, and embryo implantation capacity decreases accordingly.
- Type of Etiology: Simple tubal factor or male factor usually results in a higher cumulative pregnancy rate compared to patients with ovarian failure or severe endometrial pathology.
- Embryo Chromosomal Status: PGT-A (Preimplantation Genetic Testing for Aneuploidy) can screen for chromosomally normal embryos, but this requires obtaining a sufficient number of oocytes to form blastocysts. Patients with low ovarian reserve may not obtain enough embryos for screening.
- Uterine Environment: Endometrial thickness, morphology, presence of polyps or adhesions, and chronic endometritis all affect embryo implantation.
3. How Doctors View the Issue of Success Rate
In reproductive clinics, doctors usually do not directly promise a "probability of success." Instead, they do two things: First, assess the baseline success rate—based on the patient's age, AMH, FSH, previous cycle history, etc., they provide a reference range based on population data; Second, develop an individualized plan—by adjusting the ovulation stimulation protocol, choosing a transfer strategy, and managing comorbidities, they aim to bring the patient's "individual success rate" as close as possible to the upper limit of their age group.
Doctors are more concerned with the cumulative live birth rate rather than the clinical pregnancy rate per single transfer. The cumulative live birth rate refers to the probability of ultimately achieving a live birth from one complete oocyte retrieval cycle (including subsequent frozen embryo transfers). For patients with reasonable ovarian reserve, the cumulative live birth rate is usually significantly higher than the success rate per single transfer.
Common Clinical Dialogue:
Patient: "Doctor, my AMH is only 1.2, I'm 35. What is my success rate?"
Doctor: "Your situation indicates mildly diminished ovarian reserve, but your age is still an advantage. The probability of obtaining usable embryos from one egg retrieval is relatively high, and the expected cumulative live birth rate is still at a good level. We will first try one egg retrieval and decide on the transfer strategy based on the embryo situation. If the first transfer is not successful, you still have frozen embryos to use, so don't judge the entire cycle based on the success rate of a single transfer."
4. Differences in Success Rate Across Age Groups
Age is one of the most significant factors affecting success rate, and this is consistent across all reproductive centers. The clinical data from Xiangya Hospital Reproductive Medicine Center follows the same pattern.
- Under 35 years: Ovarian reserve is usually good, and egg quality is at a high level. The clinical pregnancy rate per transfer cycle is above 50%, and the cumulative live birth rate can reach 60%–75%. The probability of obtaining transferable embryos from a single egg retrieval is high, and some patients may even have the opportunity for PGT screening.
- 35–38 years: Egg quality begins to show measurable decline, but overall it is still within an acceptable range. The clinical pregnancy rate is approximately 40%–50%. The cumulative live birth rate is approximately 50%–62%. It is recommended for this age group to initiate assisted reproductive evaluation as soon as possible after 6 months of failed attempts to conceive.
- 38–40 years: Both egg quantity and quality decline significantly. The clinical pregnancy rate is approximately 28%–40%. The cumulative live birth rate is approximately 35%–48%. It is recommended not to spend too much time trying natural conception or simple ovulation induction; proceeding directly to an IVF cycle may be more efficient.
- 41–42 years: Ovarian reserve is significantly reduced, and the aneuploidy rate in eggs exceeds 60%. The clinical pregnancy rate is approximately 18%–28%. The cumulative live birth rate is approximately 22%–34%. PGT-A screening is often recommended, but it is necessary to assess whether there are enough eggs to form blastocysts.
- ≥43 years: The clinical pregnancy rate per transfer cycle drops to 8%–18%, and the cumulative live birth rate is approximately 10%–20%. Using autologous eggs is very challenging at this age, and doctors may discuss the feasibility and ethical procedures of egg donation.
5. Comparison of Success Rates Between Xiangya Hospital and Similar Hospitals
In China, there are over 500 medical institutions approved by the National Health Commission to carry out assisted reproductive technology, including nearly 100 institutions for preimplantation genetic diagnosis (PGD). Xiangya Hospital Reproductive Medicine Center is one of the earliest centers in China to offer assisted reproductive technology, with a complete clinical and laboratory system for reproductive medicine.
Compared with similar large tertiary hospital reproductive centers (such as Peking University Third Hospital, Shanghai Ninth People's Hospital, Renji Hospital, West China Second University Hospital, etc.), Xiangya Hospital's success rate does not show significant systematic differences. The reasons are:
- Assisted reproductive technology is highly standardized, and the core procedures (ovulation induction, egg retrieval, culture, transfer) do not differ significantly between centers.
- The main source of success rate variation is the composition of the patient population (age distribution, etiology distribution), not the technology itself.
- As a regional referral center for complex cases, Xiangya Hospital receives many older patients, those with repeated failures, and those with complicated medical conditions, which lowers the overall average success rate.
6. The Most Easily Overlooked Details: Factors Quietly Affecting Success Rate
Many patients focus all their attention on "which hospital to choose" while ignoring some equally critical details:
- Instability of Sperm Quality: The male sperm DNA fragmentation index (DFI) can fluctuate with lifestyle. Late nights, high-temperature environments, infections, and medications can all increase DFI, affecting embryo developmental potential. It is recommended to recheck semen analysis + DFI 1-3 months before egg retrieval.
- Endometrial Receptivity: Even if the embryo is chromosomally normal, implantation can fail if the endometrium has chronic inflammation (CD138 positive), polyps, adhesions, or an imbalanced microbiome. Hysteroscopy should be performed before transfer, not only after repeated implantation failure.
- Thyroid Function and Metabolic Status: TSH > 2.5 mIU/L, insulin resistance, and vitamin D deficiency are all associated with decreased implantation rates. These indicators should be optimized before starting the cycle.
- Psychological Stress and Sleep: Chronic anxiety and sleep deprivation can disrupt the hypothalamic-pituitary-adrenal axis, interfering with follicular development and endometrial receptivity. This is not just "emotional comfort" but has an endocrinological basis.
7. Common Pitfalls: Misunderstandings About Success Rate
In outpatient clinics and consultations, the following misconceptions are very common:
- Myth 1: "Success on the first try proves the hospital is good." IVF itself is a probabilistic event. A single failed transfer does not mean there is a problem with the technology. The cumulative live birth rate is a more objective indicator.
- Myth 2: "If it worked for someone else, it will definitely work for me." Everyone's ovarian reserve, age, etiology, and embryo chromosomal status are different. Others' successful experiences are not replicable.
- Myth 3: "Repeated failure means the hospital is not good." Repeated implantation failure requires systematic investigation: embryo chromosomes, endometrial receptivity, immune factors, chronic endometritis, etc. In most cases, the problem lies in the patient's own biological factors, not the laboratory technology.
- Myth 4: "The higher the success rate, the better; 90% is a good hospital." Any claim of a success rate exceeding 80%–90% should be viewed with caution, as it may involve selective reporting (only calculating for specific populations). There is no single transfer success rate above 90% in the field of assisted reproduction.
8. Interpretation of Key Examination Indicators: How They Predict Success Rate
When evaluating success rate, doctors focus on the following indicators:
| Indicator | Reference Range | Impact on Success Rate |
|---|---|---|
| AMH (Anti-Müllerian Hormone) | > 1.2 ng/mL is normal | Reflects follicular reserve. AMH < 0.8 ng/mL indicates significantly diminished ovarian reserve, reduced number of oocytes retrieved, and lower cumulative live birth rate. |
| FSH (Basal Follicle-Stimulating Hormone) | < 10 IU/L is ideal | FSH > 12 IU/L suggests diminished ovarian reserve and potentially poor response to ovulation stimulation medications. |
| LH (Luteinizing Hormone) | 2 – 8 IU/L | FSH/LH ratio > 2.5 may indicate diminished ovarian reserve. |
| Antral Follicle Count (AFC) | Total ≥ 7 on both sides | AFC < 5 usually indicates a limited number of oocytes can be retrieved, requiring adjustment of the ovulation stimulation protocol. |
| Sperm DNA Fragmentation Index (DFI) | < 15% is normal | DFI > 30% may affect blastocyst formation rate and implantation rate. |
| Endometrial Thickness (before transfer) | 7 – 14 mm | < 6 mm or > 16 mm may reduce implantation rate, but individual variation is significant. |
9. Case Scenario Analysis: The Logic Behind Three Different Outcomes
Case 1: 32 years old, AMH 2.8 ng/mL, FSH 7.2 IU/L, bilateral tubal fimbrial obstruction. Male semen normal. First cycle: 14 oocytes retrieved, 12 MII oocytes, 6 blastocysts formed, 1 blastocyst transferred, resulting in a singleton live birth.
Analysis: Age advantage + good ovarian reserve + simple etiology. This type of patient has a high cumulative live birth rate at any reputable reproductive center. A good outcome is expected, not a surprise.
Case 2: 39 years old, AMH 0.9 ng/mL, FSH 11.8 IU/L, previous ovarian cystectomy. First cycle: 4 oocytes retrieved, 3 MII oocytes, 2 embryos transferred on day 3, no pregnancy. Second cycle using a mild stimulation protocol: 3 oocytes retrieved, 1 blastocyst formed, biochemical pregnancy after transfer.
Analysis: Advanced age + diminished ovarian reserve + surgical history. Few oocytes retrieved, limited embryo numbers, each transfer opportunity is precious. This type of patient needs to manage expectations: the cumulative live birth rate is lower than for younger patients, but there is still hope. The focus should be on accumulating embryos, not on the success or failure of a single attempt.
Case 3: 42 years old, AMH 0.4 ng/mL, FSH 16.5 IU/L, basal antral follicle count 2. Male semen DFI 28%. First cycle: no oocytes retrieved. Consultation on egg donation process and ethical approval.
Analysis: Age and ovarian reserve are at extremely low levels. The probability of achieving a live birth with autologous eggs has dropped to below 10%. The doctor will honestly discuss the feasibility of egg donation. This is not a technical failure but a biological limitation.
10. When is it Suitable to Seek Treatment at Xiangya Hospital Reproductive Medicine Center
Xiangya Hospital Reproductive Medicine Center is suitable for the following groups:
- Patients living in Hunan Province or surrounding areas who require long-term follow-up and cycle monitoring.
- Patients with complex medical conditions (such as autoimmune diseases, thyroid disorders, diabetes, hypertension, etc.) requiring multidisciplinary collaborative management.
- Patients with repeated implantation failure or recurrent miscarriage who need systematic investigation of difficult etiologies.
- Patients who are carriers of genetic diseases or have chromosomal abnormalities requiring PGT (Preimplantation Genetic Testing).
When it is not suitable
- Complete ovarian failure (postmenopausal, AMH < 0.1 ng/mL, AFC 0), where autologous IVF is no longer feasible, and egg donation or adoption should be considered.
- Uncontrolled severe hypertension, diabetes, active infection, or malignant tumors; the primary disease must be treated first.
- Severe uterine malformation or severe intrauterine adhesions that cannot improve the embryo implantation environment.
Specific Process and Timeline
Initial consultation → Complete examinations (day 2-4 of menstrual cycle: sex hormones + AMH + antral follicle count, semen analysis, infectious disease screening, chromosome karyotype, uterine cavity assessment) → Develop ovulation stimulation protocol → Start cycle (approximately 10-14 days of stimulation) → Egg retrieval (outpatient procedure) → Embryo culture (3-6 days) → Transfer (fresh or frozen embryo) → Luteal phase support → Pregnancy test 12-14 days after transfer.
From the first visit to transfer, a complete cycle usually takes 2-3 months. If PGT or frozen embryo transfer is involved, the time will be extended accordingly.
What to Prepare
- Original and photocopy of both partners' ID cards and marriage certificate.
- All previous examination reports, surgical records, and discharge summaries.
- Male semen analysis report (valid within 3 months).
- Female hysterosalpingography or laparoscopy report (if available).
What are the Risks
- Ovarian Hyperstimulation Syndrome (OHSS): Higher risk in patients with polycystic ovary syndrome, but can be reduced through protocol adjustment and preventive measures.
- Risks related to egg retrieval surgery: bleeding, infection, injury to adjacent organs (incidence < 1% each).
- Risk of multiple pregnancy: When 2 embryos are transferred, the twin rate is approximately 20%–30%, and maternal and infant complications increase significantly with twin pregnancies.
- Embryo culture failure: In approximately 5%–15% of cycles, no embryos are available for transfer, mainly due to fertilization failure or embryo developmental arrest.
How to Decide if You Should Start
If any of the following conditions apply, it is recommended to visit a reproductive medicine center for evaluation as soon as possible:
- Under 35 years old, regular unprotected intercourse for more than 1 year without pregnancy.
- Over 35 years old, more than 6 months without pregnancy.
- Known tubal obstruction, severe endometriosis, or severe male oligoasthenospermia.
- History of recurrent miscarriage or repeated implantation failure.
11. Practitioner's Observation: The Real Logic Behind Success Rate
Having worked in the field of reproductive medicine for ten years, I have seen too many patients held hostage by the number "success rate." As a practitioner facing outpatient and laboratory data daily, here are a few observations for reference:
- Success rate is a population statistical concept, not a personal prophecy. For an individual, the outcome is only 0% or 100%. The so-called "probability" is just a tool to aid decision-making.
- Different doctors and different laboratory technicians in the same hospital may have slight variations in operational details, but the impact of these differences on success rate is far less than the patient's own biological factors.
- What truly deserves attention is not "which hospital has the highest success rate," but which hospital can accurately assess your condition, formulate a reasonable treatment strategy, and communicate expectations honestly.
- As a reproductive center within a large public tertiary hospital, Xiangya Hospital's advantages lie in its multidisciplinary collaboration capabilities and experience in handling complex cases, not in some "mythical success rate number."
Risk Reminder: No assisted reproductive treatment can guarantee 100% success. The success rate data mentioned in this article are industry reference ranges and do not constitute a promise of specific success rates for Xiangya Hospital Reproductive Medicine Center. When making decisions, patients should base them on their own complete examination results, communicate fully with their attending physician, and establish reasonable treatment expectations. Do not trust any claims of "guaranteed success" or "success rate above 90%." Assisted reproduction is a path that requires patience and scientific understanding. Every decision should be based on real data and medical logic.
Reference Note: The clinical pregnancy rate and cumulative live birth rate data in this article refer to the annual report of the Chinese Society of Reproductive Medicine, published cohort studies from domestic and international sources, and routine quality control data from large reproductive centers. Specific data may vary due to differences in patient population composition and statistical methods, and are intended only for understanding overall trends.
AMH FSH Antral Follicle Count Sperm DNA Fragmentation Index PGT-A Cumulative Live Birth Rate Clinical Pregnancy Rate Repeated Implantation Failure Hysteroscopy Diminished Ovarian Reserve
Comments (0)